Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ST316 by Sapience Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
ST316 is under clinical development by Sapience Therapeutics and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...